Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model ; volume:10 ; number:1 ; day:29 ; month:1 ; year:2018 ; pages:1-16 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (29.1.2018), 1-16, 12.2018
- Urheber
-
Goñi, Fernando
- Beteiligte Personen und Organisationen
-
Martá-Ariza, Mitchell
Herline, Krystal
Peyser, Daniel
Boutajangout, Allal
Mehta, Pankaj
Drummond, Eleanor
Prelli, Frances
Wisniewski, Thomas
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0337-3
- URN
-
urn:nbn:de:101:1-2018090610273063357081
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goñi, Fernando
- Martá-Ariza, Mitchell
- Herline, Krystal
- Peyser, Daniel
- Boutajangout, Allal
- Mehta, Pankaj
- Drummond, Eleanor
- Prelli, Frances
- Wisniewski, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
TDP-43 Pathology in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Role of liraglutide in Alzheimer’s disease pathology
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
TDP-43 Pathology in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Role of liraglutide in Alzheimer’s disease pathology
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
TDP-43 Pathology in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Role of liraglutide in Alzheimer’s disease pathology
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease